NEW YORK, July 5, 2018 /PRNewswire/ —

According to a recent report published by Forbes & Brightfield Group, the data projects that the global cannabis market was worth USD 7.7 Billion in the end of 2017, and is expected to reach USD 31.4 Billion by 2021. The United States accounts for about 90% of the whole market. However, the U.S. domination of the market is likely to decrease to approximately 57%, due to the legalization of cannabis products in other nations. California’s new recreational cannabis laws went into effect on January 1st, 2018. While California is the largest market, Canada is projected to show strong sales as well. Data by Deloitte report estimates the Canadian market will be worth at least USD 5 Billion in sales in 2018. CLS Holdings USA Inc. (OTC: CLSH), Supreme Cannabis Company Inc. (OTC: SPRWF), Emerald Health Therapeutics Inc. (OTC: EMHTF), Terra Tech Corp. (OTC: TRTC), iAnthus Capital Holdings Inc. (OTC: ITHUF)

In the U.S., the potential financial benefits from legalization are important economically and politically. In a report by Benzinga, Viridian Capital President, Scott Greiper, points out that the cannabis market received USD 1.23 Billion in investments in the first five weeks of 2018, up from USD 178 Million a year earlier. Viridian Capital Advisors’ Vice President, Harrison Phillips, explained, “Investments in cultivation and retail this year have been driven predominantly by the Canadian player. This has been happening pretty consistently from late 2016 through 2017. This reflects the necessity to scale cannabis businesses, to get some kind of advantage, and to explore strategic opportunities, both through acquisitions and international expansion.”

CLS Holdings USA Inc. (OTCQB: CLSH) on June 28th, announced breaking news that, “the successful closing of its acquisition of Oasis Cannabis. CLS is now active in the legalized cannabis market in Las Vegas,

Read More Here...